News from cell therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-SMALL:BCLI)

Jan 11, 2016, 10:45 ET
BrainStorm Cell Therapeutics

BrainStorm's NurOwn® for the Treatment of ALS Published in JAMA Neurology

 BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Jan 11, 2016, 07:30 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Conduct Phase 2 Multi-Dose NurOwn® Trial in ALS at Hadassah Medical Center

 BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Dec 10, 2015, 07:45 ET
BrainStorm Cell Therapeutics

BrainStorm Reschedules Corporate Update Conference Call to January 11, 2016

 BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Dec 07, 2015, 01:00 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Announces Appointment of Dr. Revital Geffen-Aricha as Vice President of Research & Development

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...

Dec 02, 2015, 09:10 ET
BrainStorm Cell Therapeutics

BrainStorm Hosting Conference Call to Update Shareholders on Important Developments

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...

Dec 01, 2015, 08:00 ET
BrainStorm Cell Therapeutics

BrainStorm and Octane Biotech Announce Success in Cocoon™ Application Development Based on Customized Bioreactor for NurOwn® Stem Cells

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, and Octane...

Nov 30, 2015, 02:29 ET
BrainStorm Cell Therapeutics

BrainStorm Awarded Additional $735,000 Non-Dilutive Grant for 2015 from Israel's Office of the Chief Scientist

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Nov 17, 2015, 07:00 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Reports Third Quarter 2015 Financial Results And Provides Corporate Update

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Nov 09, 2015, 08:00 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...

Oct 26, 2015, 16:33 ET

CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock

 CTI BioPharma Corp. ("CTI") (NASDAQ and MTA: CTIC) today announced that it intends to offer and sell, subject to market and other conditions,...

Oct 16, 2015, 08:03 ET
BrainStorm Cell Therapeutics

BrainStorm Strengthens Intellectual Property Position - Granted Patent for Company's NurOwn® Technology Platform

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Oct 08, 2015, 07:14 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics' Chief Scientific Advisor to Present At The 2015 FENS-RM in Thessaloniki, Greece

 BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announces...

Oct 07, 2015, 09:36 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Treatment of Final Patient in US Multicenter Double Blinded Phase 2 ALS Trial

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...

Oct 01, 2015, 08:03 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Present at 2015 Stem Cell Meeting on the Mesa

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will be...

Sep 22, 2015, 17:00 ET
BrainStorm Cell Therapeutics

BrainStorm Announces Appointment of Chaim Lebovits as Chief Executive Officer

 BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Sep 02, 2015, 07:15 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Present at Rodman & Renshaw 17th Annual Global Investment Conference

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Aug 13, 2015, 06:55 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...

Aug 11, 2015, 08:05 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of NurOwn® in ALS

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Aug 06, 2015, 08:55 ET
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics to Report Second Quarter 2015 Financial Results on Thursday, August 13

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases,...

Aug 03, 2015, 06:55 ET
BrainStorm Cell Therapeutics

BrainStorm Strengthens Executive Team: Announces the Appointment of Yoram Bibring as Chief Financial Officer

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...